Government-Led Healthcare Research And Development Initiatives A Boost For Oligonucleotide Therapy Is Supporting Development Across The Oligonucleotide Therapy Market

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Is The Forecasted Rise In Market Size Of The Oligonucleotide Therapy Market During The Forecast Period?

The oligonucleotide therapy market has witnessed rapid expansion in recent years. Its size is projected to increase from $6.2 billion in 2025 to $6.91 billion in 2026, at a compound annual growth rate (CAGR) of 11.5%. The historical growth of this market can be attributed to several factors such as increasing research and development in oligonucleotide synthesis, a growing demand for targeted therapies, advancements in molecular biology techniques, a rise in chronic and genetic diseases, and the early adoption of antisense and aptamer technologies.

The oligonucleotide therapy market is projected to experience substantial expansion in the coming years. Its valuation is anticipated to reach $10.87 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 12.0%. Factors contributing to this growth during the forecast period include the increasing adoption of personalized medicine, the incorporation of AI into drug discovery processes, the advancement of precision medicine initiatives, the creation of next-generation delivery platforms, and a rise in collaborations between biotechnology and pharmaceutical firms. Key developments expected within this period encompass targeted gene regulation, therapeutics based on RNA interference, the evolution of personalized medicine, sophisticated drug delivery systems, and diagnostics utilizing nucleic acids.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3398&type=smp

What Are The Main Drivers Accelerating The Growth Of The Oligonucleotide Therapy Market?

The oligonucleotide therapy market is expected to grow, propelled by government initiatives for research and development within the healthcare sector. These government initiatives refer to specific actions, programs, policies, or projects undertaken by governmental authorities at various levels—local, regional, national, or international—to address particular issues, achieve set goals, or bring about positive societal changes. Many government authorities are launching various healthcare initiatives to support different aspects, including oligonucleotide therapy. For instance, in April 2025, according to the American Medical Association, a US-based professional organization, U.S. health spending increased by 7.5% in 2023, reaching $4.9 trillion, or $14,570 per capita, which exceeded the 4.6% increase observed in 2022. Therefore, government initiatives supporting research and development in healthcare are driving the expansion of the oligonucleotide therapy market.

How Is The Oligonucleotide Therapy Market Distributed Across Key Segments?

The oligonucleotide therapy market covered in this report is segmented –

1) By Type: Antisense Oligonucleotide, Aptamer, Other Types

2) By Application: Infectious Diseases, Oncology, Neurodegenerative Disorders, Cardiovascular Diseases, Kidney Diseases, Other End-User

3) By End User: Hospitals, Research Institutes

Subsegments:

1) By Antisense Oligonucleotide: RNA-Targeted Antisense Oligonucleotides, DNA-Targeted Antisense Oligonucleotides, Chemically Modified Antisense Oligonucleotides

2) By Aptamer: DNA Aptamers, RNA Aptamers, Small Molecule Aptamers

3) By Other Types: siRNA (Small Interfering RNA), miRNA (Micro RNA), DNAzyme And Ribozymes, Synthetic Oligonucleotides For Gene Editing

Which Trends Are Contributing To Changes In The Oligonucleotide Therapy Market?

Leading companies in the oligonucleotide therapy market are concentrating on creating sophisticated treatments, such as gene therapies, to tackle the underlying causes of genetic diseases, enhance patient outcomes, and alleviate the long-term burden of care. Gene therapies are innovative medical interventions designed to introduce a functional gene into a patient’s cells to compensate for a non-functional or mutated one. For instance, in June 2023, Sarepta Therapeutics Inc., a US-based biotechnology company, obtained Food and Drug administration (FDA) approval for ELEVIDYS. This therapy is a first-of-its-kind gene treatment for ambulatory pediatric patients with Duchenne muscular dystrophy (DMD). It is a single-dose treatment formulated to deliver a gene that codes for a shortened functional form of dystrophin to muscle cells, aiming to halt or reverse the progression of the disease.

Which Industry Players Are Present In The Oligonucleotide Therapy Market?

Major companies operating in the oligonucleotide therapy market are Pfizer Inc., GlaxoSmithKline plc, Gilead Sciences Inc., Biogen Inc., Alnylam Pharmaceuticals Inc., Sarepta Therapeutics Inc., Ionis Pharmaceuticals Inc., Akcea Therapeutics Inc., Arrowhead Pharmaceuticals Inc., Dicerna Pharmaceuticals Inc., SomaGenics Inc., Wave Life Sciences Ltd., Exicure Inc., Avidity Biosciences Inc., Miragen Therapeutics Inc., ProQR Therapeutics NV, Regulus Therapeutics Inc., Kastle Therapeutics LLC, Santaris Pharma A/S, InteRNA Technologies B.V., Evox Therapeutics Ltd., PepGen Ltd.

Access The Complete Oligonucleotide Therapy Market Report:

https://www.thebusinessresearchcompany.com/report/oligonucleotides-therapy-global-market-report

Which Regional Market Leads The Oligonucleotide Therapy Market?

North America was the largest region in the oligonucleotide therapy market in 2025. The regions covered in the oligonucleotide therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Oligonucleotide Therapy Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=3398&type=smp

Browse Through More Reports Similar to the Global Oligonucleotide Therapy Market 2026, By The Business Research Company

Oligonucleotides Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/oligonucleotides-therapy-global-market-report

Oligonucleotide Synthesis Market Report 2026

https://www.thebusinessresearchcompany.com/report/oligonucleotide-synthesis-global-market-report

Nucleic Acid Based Gene Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/nucleic-acid-based-gene-therapy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795